Pancreatic Cancer Research

ResearcherUniversitätsmedizin GöttingenActive in the last 2 years

Azadeh Azizian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4270-5706; OpenAlex author ID A5020364857. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 4 papers

Papers 8

  1. ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer. Co-author DOI 10.1002/ijc.34960↗
  2. LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism. Co-author DOI 10.1093/carcin/bgae011↗
  3. MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK-ERK and AP-1 pathways. Co-author DOI 10.1093/carcin/bgae025↗
  4. ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer. Co-author DOI 10.1093/carcin/bgae056↗
  5. SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2023.113434↗
  6. Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients. Co-author DOI 10.1093/carcin/bgac092↗
  7. NO• /RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer. Co-author DOI 10.1002/ijc.32733↗
  8. CA19-9 for detecting recurrence of pancreatic cancer. Co-author DOI 10.1038/s41598-020-57930-x↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jochen Gaedcke · 8 shared papers, 2020–2024 · strength 1.23
  2. Nader N Hanna · 7 shared papers, 2020–2024 · strength 1.12
  3. S. Perwez Hussain · 7 shared papers, 2020–2024 · strength 1.12
  4. Yuuki Ohara · 6 shared papers, 2022–2024 · strength 1.03
  5. Michael B. Ghadimi · 6 shared papers, 2020–2024 · strength 1.01
  6. Paloma Moreno · 4 shared papers, 2023–2024 · strength 0.72
  7. Shouhui Yang · 4 shared papers, 2020–2024 · strength 0.56
  8. S. S. Yang · 3 shared papers, 2024 · strength 0.56
  9. Β. Michael Ghadimi · 2 shared papers, 2020–2022 · strength 0.22
  10. Lin Zhang · 1 shared paper, 2024 · strength 0.18
  11. Jianjun Gao · 1 shared paper, 2024 · strength 0.18
  12. Subrata Sen · 1 shared paper, 2024 · strength 0.18
  13. Nagireddy Putluri · 1 shared paper, 2024 · strength 0.18
  14. Lin Zhang · 1 shared paper, 2022 · strength 0.13
  15. Peter Jo · 1 shared paper, 2020 · strength 0.11
  16. Alexander Otto König · 1 shared paper, 2020 · strength 0.11
  17. Limin Wang · 1 shared paper, 2020 · strength 0.09
  18. Dong Ho Lee · 1 shared paper, 2020 · strength 0.09
  19. Jian Wang · 1 shared paper, 2020 · strength 0.09
  20. H. Richard Alexander · 1 shared paper, 2020 · strength 0.09
  21. Matthias M. Gaida · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.